Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9314-9324

  Lieber, André ^a   Steinwaerder, Dirk S ^a   Carlson, Cheryl A ^a   Kay, Mark A ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REPETITIVE DNA; VIRUS PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTICLE; DNA PACKAGING; GENE INSERTION; GENE REARRANGEMENT; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOUTHERN BLOTTING; TRANSGENE; VIRUS GENE; VIRUS HYBRID;

EID: 0032876839     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9314-9324.1999     Document Type: Article

References (41)

1. Alexander, I. E., D. W. Russell, A. M. Spence, and A. D. Miller. 1996. Effects of gamma irradiation on the transduction of nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7:841-850.
2. Balague, C., M. Kalla, and W.-W. Zhang. 1997. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71:3299-3306.
3. Conway, J. E., S. Zolotuchin, N. Muzyczka, G. S. Hayward, and B. J. Byrne. 1997. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing rep and cap. J. Virol. 71:8780-8789.
4. Doerfler, W. 1993. Adenoviral DNA integration and changes in DNA methylation patterns: a different view of insertional mutagenesis. Prog. Nucleic Acid Res. Mol. Biol. 46:1-37.
5. Feng, M., W. R. Jackson, C. K. Goldman, C. Rancourt, M. Wang, S. K. Dusing, G. Siegal, and D. T. Curiel. 1997. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat. Biotechnol. 15:866-870.
6. Fisher, K. J., W. M. Kelley, J. F. Burda, and J. M. Wilson. 1996. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome. Hum. Gene Ther. 7:2079-2087.
7. Fisher, K. J., K. Joos, J. Alston, Y. Yang, S. E. Hacecker, K. High, R. Pathak, S. E. Raper, and J. M. Wilson. 1997. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:306-312.
8. Fisher, K. J., H. Choi, J. Burda, S. Chen, and J. M. Wilson. 1996. Recombinant adenovirus deleted of all genes for gene therapy of cystic fibrosis. Virology 217:11-22.
9. Gluzman, Y., and K. Van-Doren. 1983. Palindromic adenovirus type 5-SV40 hybrids. J. Virol. 45:91-103.
10. Haecker, S. E., H. H. Stedman, R. J. Balice-Gordon, D. B. J. Smith, J. P. Greelish, M. A. Mitchell, A. Wells, H. L. Sweeney, and J. M. Wilson. 1996. In vivo expression of full-length human dystrophin from adenoviral vectors deleted for all viral genes. Hum. Gene Ther. 7:1907-1914.
11. Heffelfinger, S. C., H. H. Hawkins, J. Barrish, L. Taylor, and G. J. Darlington. 1992. SKHEp1: a human cell line of endothelial origin. In Vitro Cell. Dev. Biol. 28A:136-142.
12. Hitt, M. M., C. L. Addison, and F. L. Graham. 1997 Human adenoviral vectors for gene transfer into mammalian cells. Adv. Pharmacol. 40:137-205.
13. Inoue, N., and D. W. Russell. 1998. Packaging cells based an inducible gene amplification for the production of AAV vectors. J. Virol. 72:7024-7031.
14. Johnston, K. M., D. Jakoby, P. A. Pechan, C. Fraefel, P. Borghesani, D. Schuback, R. J. Dunn, F. I. Smith, and X. O. Breakfield. 1997. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8:359-370.
15. Kay, M. A., F. Graham, F. Leland, and S. L. Woo. 1995. Therapeutic serum concentrations of human alpha 1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21:815-819.
16. Kotin, R. M. 1994. Prospects for the use of adeno-associated virus vectors for human gene therapy. Hum. Gene Ther. 5:793-801.
17. Kumar-Singh, R., and D. B. Farber. 1998. Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: application to the rescue of photoreceptor degeneration. Hum. Mol. Genet. 7:1893-1900.
18. Leblois, H., C. Orsini, P. Yeh, and M. Perricaudet. 1998. Adenovirus-mediated delivery of an EBV-based replicon via Cre/loxP recombination: a novel vector system for efficient and long-term gene expression, abstr. 705, p. 177a. Presented at the 1st meeting of the American Society of Gene Therapy. American Society of Gene Therapy, Thorofare, N.J.
19. Lieber, A., C.-Y. He, and M. A. Kay. 1997. Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo. Nat. Biotechnol. 15:1383-1387.
20. Lieber, A., C.-Y. He, I. Kirillova, and M. A. Kay. 1996. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70:8944-8960.
21. Lieber, A., C.-Y. He, L. Meuse, D. Schowalter, I. Kirillova, B. Winther, and M. A. Kay. 1997. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71:8798-8807.
22. Lyu, Y. L., C.-T. Lin, and L. F. Liu. 1999. Inversion/dimerization of plasmids mediated by inverted repeats. J. Mol. Biol. 285:1485-1501.
23. Malik, P., S. A. McQuiston, X.-J. Yu, K. A. Pepper, W. J. Krall, G. M. Podsakoff, G. J. Kurtzman, and D. B. Kohn. 1997. Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J. Virol. 71:1776-1783.
24. Miao, C. H., R. O. Snyder, D. B. Schowalter, G. A. Patjin, B. Donahue, B. Winther, and M. A. Kay. 1998. The kinetics of rAAV integration in the liver. Nat. Genet. 19:13-15.
25. Muzyczka, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:97-129.
26. Nakai, H., Y. Iwaki, M. A. Kay, and L. B. Couto. 1999. Isolation of recombinant AAV vector-cellular DNA junctions from mouse liver. J. Virol. 73: 5438-5447.
27. Nelson, J., and M. A. Kay. 1997. Persistence of recombinant adenovirus in vivo is not dependent on vector replication. J. Virol. 71:8902-8907.
28. Parks, R. J., and F. L. Graham. 1997. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J. Virol. 71:3293-3298.
29. Pearson, C. E., H. Zorbas, G. B. Price, and M. Zannis-Hadjopoulos. 1996. Inverted repeats, stem loops, and cruciforms: significance for initiation of DNA replication. J. Cell. Biochem. 63:1-22.
30. Peterson, K. R., C. H. Clegg, P. A. Navas, E. J. Norton, T. G. Kimbrough, and G. Stamatoyannopoulos. 1996. Effect of deletion of 5′HS3 or 5′HS2 of the human B-globin locus control region on the developmental regulation of globin gene expression in B-globin locus yeast artificial chromosome transgenic mice. Proc. Natl. Acad. Sci. USA 93:6605-6609.
31. Recchia, A., R. J. Parks, S. Lamartina, C. Toniatti, L. Pieroni, F. Palombo, G. Ciliberto, F. L. Graham, R. Cortese, N. La Monica, and S. Colloca. 1999. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 96:2615-2620.
32. Russell, D., I. E. Alexander, and A. D. Miller. 1995. DNA synthesis and topoisomerase inhibitors increase transaction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 92:5719-5723.
33. Russell, D. W., A. D. Miller, and I. E. Alexander. 1994. AAV vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91:8915-8919.
34. Rutledge, E. A., and D. W. Russell. 1997. Adeno-associated virus vector integration junctions. J. Virol. 71:8429-8436.
35. Samulski, R. J., L. S. Chang, and T. Shenk. 1989. Helper free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3928.
36. Steinwaerder, D., C. A. Carlson, and A. Lieber. 1999. Generation of adeno-virus vectors devoid of all viral genes by recombination between inverted repeats. J. Virol. 73:9303-9313.
37. Xiao, X., J. Li, and R. J. Samulski. 1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.
38. Xiao, X., W. Xiao, J. Li, and R. J. Samulski. 1997. A novel 165-bp terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J. Virol. 71:941-948.
39. Xiao, X., J. Li, and R. J. Samulski. 1998. Production of hight-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72:2224-2232.
40. Yalkinoglu, A. O., H. Zentgraf, and U. Hubscher. 1991. Origin of adeno-associated virus DNA replication is a target for carcinogen-inducible DNA amplification. J. Virol. 65:3175-3184.
41. Yang, C. C., X. Xiao, X. Zhu, D. C. Ansardi, N. D. Epstein, M. R. Frey, A. G. Matera, and R. J. Samulski. 1997. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71:9231-9247.